197 related articles for article (PubMed ID: 32167618)
1. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J
Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618
[TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.
Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J
Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070
[TBL] [Abstract][Full Text] [Related]
3. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract][Full Text] [Related]
4. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Significance of Serum MASP-2 and IDH1 in the Early Diagnosis of Non-Small Cell Lung Cancer.
Chen Y; Wu ED; Ma S; Bai WQ; Yin YJ; Shi GL
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180422
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
7. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
9. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
10. IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.
Li JJ; Li R; Wang W; Zhang B; Song X; Zhang C; Gao Y; Liao Q; He Y; You S; Tan Z; Luo X; Li Y; Tang M; Weng X; Yi W; Peng S; Liu S; Tan Y; Bode AM; Cao Y
Mol Oncol; 2018 May; 12(5):602-610. PubMed ID: 29465809
[TBL] [Abstract][Full Text] [Related]
11. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
[TBL] [Abstract][Full Text] [Related]
12. Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Cao YT; Li JH; Wang YT; Fu YW; Xu J
Tumori; 2014; 100(2):214-8. PubMed ID: 24852868
[TBL] [Abstract][Full Text] [Related]
13. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
[TBL] [Abstract][Full Text] [Related]
15. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
16. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
17. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
18. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
19. The isocitrate dehydrogenase 1 is a potential prognostic indicator for non-small cell lung cancer patients.
Zhang X; Ma S; Chen Y; Yin Y; Bai W; Tan J; Shi G
Int J Biol Markers; 2021 Dec; 36(4):27-35. PubMed ID: 34761718
[TBL] [Abstract][Full Text] [Related]
20. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
